首頁 › 瀰漫性內生性橋腦膠質瘤 › 賓夕法尼亞州 › Philadelphia
Philadelphia, PA 的 瀰漫性內生性橋腦膠質瘤 臨床試驗
10 項針對 瀰漫性內生性橋腦膠質瘤 的研究正在 Philadelphia(約 30 英里範圍內)及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本(英文)
正在為研究招募對象嗎?將此頁面置頂展示 — $99 / 30 天 →
CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma
招募中1/2 期
- Children's Hospital of Philadelphia, Philadelphia
Targeted Pediatric High-Grade Glioma Therapy
招募中觀察性研究
- Children's Hospital of Philadelphia, Philadelphia
Study of Olutasidenib and Temozolomide in HGG
招募中2 期
- Children's Hospital of Philadelphia, Philadelphia
PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma
招募中2 期
- Children's Hospital of Philadelphia, Philadelphia
Illuminate: A Clinical Study Evaluating CAR T Immune Cell Therapy (BCB-276) for Patients With Diffuse Intrinsic Pontine Glioma (DIPG).
招募中2 期
- Children's Hospital of Philadelphia, Philadelphia
Lutathera for Treatment of Recurrent or Progressive High-Grade CNS Tumors
招募中1/2 期
- Children's Hospital of Philadelphia, Philadelphia
Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion
招募中早期第 1 期歡迎健康志工
- Children's Hospital of Philadelphia, Philadelphia
Combination Therapy for the Treatment of Diffuse Midline Gliomas
招募中2 期
- Children's Hospital of Philadelphia, Philadelphia
Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant
招募中2 期
- Children's Hospital of Philadelphia, Philadelphia
A Pilot Study of Larotrectinib for Newly-Diagnosed High-Grade Glioma With NTRK Fusion
招募中早期第 1 期
- Children's Hospital of Philadelphia, Philadelphia
其他城市的 瀰漫性內生性橋腦膠質瘤 試驗
- Washington, DC11 項研究
- Columbus, OH10 項研究
- Seattle, WA10 項研究
- Cincinnati, OH10 項研究
- Houston, TX10 項研究
- Chicago, IL9 項研究
- Durham, NC9 項研究
- Boston, MA9 項研究
- Aurora, CO8 項研究
- Miami, FL6 項研究
- Ann Arbor, MI6 項研究
- St. Louis, MO5 項研究
Philadelphia 的其他研究
- 癌症(所有類型)59 項研究
- 乳癌56 項研究
- 非小細胞肺癌51 項研究
- 轉移性癌症46 項研究
- 前列腺癌44 項研究
- 大腸直腸癌44 項研究
- 卵巢癌44 項研究
- 肺癌36 項研究
- 急性髓系白血病34 項研究
- 心臟衰竭31 項研究
- 子宮內膜癌28 項研究
- 憂鬱症26 項研究
資料來源:ClinicalTrials.gov,擷取日期 2026年10月6日。各研究自行設定資格標準;由研究團隊決定參與者資格。